who created retatrutide Makes Retatrutide? Company Behind the Weight Loss Drug Eli Lillys retatrutide what is

The GLP-3 RT supplied here is for laboratory and research use only, and is not approved for diagnostic, therapeutic, or human use.

Following the healthcare providers guidance ensures the best results and helps patients to achieve and maintain the resulting weight loss over the long term

The glucagon receptor activation in Retatrutide provides metabolic benefits beyond weight loss that Tirzepatide cannot match

No other peptide in development has matched these numbers

The most important contextual factor for anyone starting a compounded GLP-1 program in June 2026 isn't specific to Omzo - it's the FDA's April 30, 2026 proposal that would restrict large-scale 503B compounding of semaglutide and tirzepatide